These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37409273)

  • 21. [Ultrastructural study of podocyte alterations in non proliferative glomerulopathy].
    Sipovsky VG; Nevorotin AI; Avsiewitsch IV; Smirnov AV
    Arkh Patol; 2019; 81(3):51-58. PubMed ID: 31317931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New risk score for predicting steroid resistance in patients with focal segmental glomerulosclerosis or minimal change disease.
    Weng Q; Zhou Q; Tong J; Jin Y; Liu Y; Yu X; Pan X; Ren H; Wang W; Xie J; Chen N
    Clin Proteomics; 2020; 17():18. PubMed ID: 32514258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.
    Pérez V; López D; Boixadera E; Ibernón M; Espinal A; Bonet J; Romero R
    BMC Nephrol; 2017 Feb; 18(1):49. PubMed ID: 28158993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
    Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ
    Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS.
    Li F; Zheng C; Zhong Y; Zeng C; Xu F; Yin R; Jiang Q; Zhou M; Liu Z
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1903-11. PubMed ID: 25318750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Prospective Study on Complement Activation Distinguishes Focal Segmental Glomerulosclerosis from Minimal Change Disease.
    Cambier A; Patey N; Royal V; Gougeon F; Genest DS; Brachemi S; Bollée G; Merlen C; Bonnefoy A; Lapeyraque AL; Troyanov S
    Kidney Int Rep; 2024 Mar; 9(3):661-670. PubMed ID: 38481495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult primary nephrotic syndrome trends by race: a diminished frequency of focal segmental glomerulosclerosis in non-black patients.
    Mbakop C; DeVita MV; Wahl SJ; Bijol V; Rosenstock JL
    Int Urol Nephrol; 2021 Apr; 53(4):719-724. PubMed ID: 33200335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New Anti-Nephrin Antibody Mediated Podocyte Injury Model Using a C57BL/6 Mouse Strain.
    Takeuchi K; Naito S; Kawashima N; Ishigaki N; Sano T; Kamata K; Takeuchi Y
    Nephron; 2018; 138(1):71-87. PubMed ID: 28965116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct metabolic profile of primary focal segmental glomerulosclerosis revealed by NMR-based metabolomics.
    Hao X; Liu X; Wang W; Ren H; Xie J; Shen P; Lin D; Chen N
    PLoS One; 2013; 8(11):e78531. PubMed ID: 24244321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Diagnostic Potential of uPAR as a Biomarker in Renal Biopsies of Patients with FSGS.
    da Silva CA; Araújo LS; Dos Reis Monteiro MLG; de Morais Pereira LH; da Silva MV; Castellano LRC; Corrêa RRM; Dos Reis MA; Machado JR
    Dis Markers; 2019; 2019():1070495. PubMed ID: 31191741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factors.
    Rashmi P; Sigdel TK; Rychkov D; Damm I; Da Silva AA; Vincenti F; Lourenco AL; Craik CS; Reiser J; Sarwal MM
    Ann Transl Med; 2023 Jun; 11(9):315. PubMed ID: 37404982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline characteristics and long-term outcomes of steroid-resistant nephrotic syndrome in children: impact of initial kidney histology.
    Watanabe Y; Fujinaga S; Endo A; Endo S; Nakagawa M; Sakuraya K
    Pediatr Nephrol; 2020 Dec; 35(12):2377-2381. PubMed ID: 32964318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
    Agrawal V; Prasad N; Jain M; Pandey R
    Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
    Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
    Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenic Role of MicroRNA Dysregulation in Podocytopathies.
    Liu F; Chen J; Luo C; Meng X
    Front Physiol; 2022; 13():948094. PubMed ID: 35845986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis.
    Siligato R; Cernaro V; Nardi C; De Gregorio F; Gembillo G; Costantino G; Conti G; Buemi M; Santoro D
    Expert Opin Investig Drugs; 2018 Nov; 27(11):839-879. PubMed ID: 30360670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimal change disease and idiopathic FSGS: manifestations of the same disease.
    Maas RJ; Deegens JK; Smeets B; Moeller MJ; Wetzels JF
    Nat Rev Nephrol; 2016 Dec; 12(12):768-776. PubMed ID: 27748392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical evaluation of podocalyxin expression in glomerulopathies associated with nephrotic syndrome.
    Kavoura E; Gakiopoulou H; Paraskevakou H; Marinaki S; Agrogiannis G; Stofas A; Boletis I; Patsouris E; Lazaris AC
    Hum Pathol; 2011 Feb; 42(2):227-35. PubMed ID: 21106221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The spectrum of biopsy-proven glomerular diseases in a tertiary Hospital in Southern Brazil.
    Thomé GG; Bianchini T; Bringhenti RN; Schaefer PG; Barros EJG; Veronese FV
    BMC Nephrol; 2021 Dec; 22(1):414. PubMed ID: 34903188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic Analysis of Idiopathic Nephrotic Syndrome Triggered by Primary Podocytopathies in Adults: Regulatory Mechanisms and Diagnostic Implications.
    Chen Q; Xu J; Liu L; Ye Q; Lin W; Liao Y; Gao R; Zhang X; Chen R; Xiong Y; Chen S; Ye X; Wei L
    J Proteome Res; 2024 Jun; 23(6):2090-2099. PubMed ID: 38728052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.